ENCBS010BHG / cell line
Summary
- Status
- released
- Term name
- HCT116
- Term ID
- EFO:0002824
- Summary
- Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21
- Description
- in situ Hi-C of human cell line: HCT-116-RAD21-mAC cells
- Starting amount
- 8400000cells
- Culture harvest date
- 2017-04-21
Attribution
ENCODE4 project
- Lab
- Erez Aiden, Baylor
- Award PI
- Erez Aiden, Baylor
- Submitted by
- Neva Durand
- Source
- Dr. Masato Kanemaki
- Project
- ENCODE
- External resources
- Aliases
- erez-aiden:HCT-116-RAD21-mAC-no-auxin-biorep4
Genetic modifications
Accession | Category | Purpose | Method | Nucleic acid delivery method | Site |
|---|---|---|---|---|---|
| ENCGM785YNS | insertion | tagging | CRISPR |
| |
| ENCGM489TXA | insertion | expression | CRISPR | ||
| ENCGM561PJN | insertion | tagging | CRISPR |
|
Donor information
- Status
- released
- Accession
- ENCDO000ABE
- Aliases
- encode:donor of HCT-116, bradley-bernstein:Donor of HCT-116 cells
- Species
- Homo sapiens
- Life stage
- adult
- Age
- 48 years
- Sex
- male
- Health status
- colorectal carcinoma
- External resources
- References